Can't read this email? Please CLICK HERE to view it in your browser.

 

Sustainability and Emerging Applications Centre Conference 2020

23 - 24 September 2020

Note: This is a non-chargeable Conference. Registration is required for participants to receive the Webinar link. Please register with your full name to address you correctly.
 

23rd September, Wednesday
Day 1: Microfluidics Technologies for Point-of-Care Diagnostics in Medical/ Healthcare Applications

PROGRAMME  

9.00am
Welcome Address
Dr David Low, Executive Director, SIMTech

9.10am
Microfluidics for the Rapid Testing of COVID-19
Prof Lim Chwee Teck, Professor, Department of Biomedical Engineering, NUS   

9.35am
Enabling Therapeutic Drug Testing and Monitoring for Precision Medicine with POCT 
Mr Guo Dongliang, Managing Director, Vishuo Biomedical  

10.00am
Commercialisation of COVID-19 Diagnostic Product
Dr Johnson Ng, CEO, JN Medsys

10.25am
BREAK

10.35am
Advances in Organ-on-Chip Technologies for the Chemical and Personal Care Industries
Dr Alberti Massimo, CTO, Revivo Biosystems

​​​​11.00am
Microfluidics Capability and Development in SIMTech for Diagnostic Applications
Dr Charles Wang, Group Manager, SMF, SIMTech

11.25am
Panel Discussion

12:00pm
End

Speakers

Professor Lim Chwee Teck is the NUS Society Chair Professor, Founding PI of Mechanobiology Institute and Director of the Institute for Health Innovation and Technology (iHealthtech) at NUS. He is also the Founding Director of the Singapore Health Technologies Consortium. His research interests are in the human disease mechanobiology and microfluidics for disease diagnosis, precision therapy and flexible wearable technologies.

Mr Guo Dongliang is a biomedical entrepreneur with 20 years of broad industry experience in Bioinformatics, IVD and Drug discovery. As the founder of Vishuo Biomedical, he has led the company from early product development to commercialisation in over 10 countries.

Dr Johnson Ng is the founder of JN Medsys, a life science company that builds genomic tools for precision diagnostics. Under the leadership of Dr Ng, JN Medsys became the first Asian company to commercialise a digital PCR system, and only one of a handful in the world, winning it a Frost & Sullivan innovation award in 2017.

Dr Alberti Massimo is the founder of REVIVO Biosystems, a spin-off of A*STAR that aims to commercialise the organ-on-chip technology. His research interests lie in the fields of organ-on-chip and tissue engineering.

Dr Charles Wang is a group manager and senior scientist at SIMTech’s Smart Microfluidics Group. He obtained his PhD in Biomedical Engineering from the Nanyang Technological University of Singapore, and has more than 15 years of experience in microfluidics technologies.

CONTACT US
For more information, please contact

Dr Gary Ng                                                                   
Centre Director, SEAC, SIMTech
Email: shng@SIMTech.a-star.edu.sg

Ms Pearl Tan
Industry Development Manager, SEAC, SIMTech
Email: tanmyp@SIMTech.a-star.edu.sg

 

Connect with us